The "Concussion or Brain Bleed" Trial
NCT04002505 is an interventional trial sponsored by Mayo Clinic. As of 21 Nov 2026, it is enrolling by invitation only. It studies Head Injury. The registry lists an enrollment of 370 participants at 1 site in 1 country. The registry lists a start date of 27 Jun 2019 and a primary completion date of 31 Dec 2030.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT04002505 |
| Status | Enrolling by invitation |
| Study type | Interventional trial |
| Lead sponsor | Mayo Clinic |
| Enrollment | 370 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Head Injury |
| Start | 27 Jun 2019 |
| Primary completion | 31 Dec 2030 |
| Study completion | 31 Dec 2030 |
| Last update posted | 29 May 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Neha Raukar, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic in Rochester
Rochester
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT04002505
Each answer restates registry values shown on this page.
What is NCT04002505?
NCT04002505 is an interventional trial sponsored by Mayo Clinic. It studies Head Injury.
Is NCT04002505 recruiting?
As of 21 Nov 2026, it is enrolling by invitation only.
Who leads NCT04002505?
The registry names Neha Raukar, MD (principal investigator, Mayo Clinic) as the overall official.
Where does NCT04002505 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT04002505 expected to complete?
The registry lists a primary completion date of 31 Dec 2030 and a study completion date of 31 Dec 2030. The sponsor last updated the record on 29 May 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.